In 2022, multiple sclerosis (MS) treatments performed in Australia and New Zealand had a market share of about 19.6 percent in the Asia Pacific region. The market share was forecast to gradually decline to around 16.9 percent by 2028.
Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028
Characteristic
Market share
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Reports and Insights. (April 6, 2023). Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028 [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights. "Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028." Chart. April 6, 2023. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights. (2023). Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights. "Market Share in The Asia Pacific (Apac) Region of Multiple Sclerosis (Ms) Treatments Performed in Australia and New Zealand from 2017 to 2022 with a Forecast until 2028." Statista, Statista Inc., 6 Apr 2023, https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights, Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028 Statista, https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/ (last visited July 22, 2024)
Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028 [Graph], Reports and Insights, April 6, 2023. [Online]. Available: https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/